Revenue of Fosun Pharmaceutical 2019-2023

Published by
Wenyi Zhang,
Nov 18, 2024

In 2023, the Chinese pharmaceutical firm Fosun Pharmaceutical generated 41.25 billion yuan of revenue, representing a drop of 5.84 percent from the previous year. The company is one of the leaders in the Chinese pharmaceutical sector, which formed a strategic alliance with BioNTech in the early days of the COVID-19 pandemic in 2020.

Annual revenue of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. from 2019 to 2023 (in billion yuan)

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

March 2024

Region

China

Survey time period

2019 to 2023

Supplementary notes

One yuan equals approximately 0.14 U.S. dollars and 0.13 euros (as of November 2024).

Figures prior to 2022 have been retrieved from the previous publications.
Figures have been rounded for a better understanding.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Jiangsu Hengrui Pharmaceuticals "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Jiangsu Hengrui Pharmaceuticals

Company positioning

6

Key company data

8

Research and development

5

Competitors

5

The oncology drug market

4

Further Content: You might find this interesting as well

Topics

Hengrui PharmaceuticalsMedical technology in ChinaPfizerJohnson & JohnsonPharmaceutical industry in Japan
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.